The federal government continues its halting effort to field an enterprise cloud strategy, with Lt. Gen. Jack Shanahan, who leads the Defense Department's Joint AI Center (JAIC), commenting recently that not having an enterprise cloud platform has made the government's efforts to pursue AI more challenging. "The lack of an enterprise solution has slowed us down," stated Shanahan during an AFCEA DC virtual event held on May 21, according to an account in FCW. However, "the gears are in motion" with the JAIC using an "alternate platform" for example to host a newer anti-COVID effort. This platform is called Project Salus, and is a data aggregation that is able to employ predictive modeling to help supply equipment needed by front-line workers. The Salus platform was used for the ill-fated Project Maven, a DOD effort that was to employ AI image recognition to improve drone strike accuracy.
Three companies – Samsung, IBM and Tencent – dominate the global AI patent race over the past 10 years, while fierce competition between the U.S, and China overshadows other countries and regions, including the EU. These are the key findings of OxFirst, a specialist in IP law and economics (and spin out of Oxford University), which also reported that multiple neural nets, machine learning and speech recognition are driving the market. "Patents are mainly filed in the area of interconnectivity and system architecture, suggesting that top players focus primarily on protecting technologies covering multiple neural nets," OxFirst said in its announcement today. "Other areas of crucial importance are ML and bootstrap methods, alongside procedures used during speech recognition processes; e.g. the further establishment of human-machine dialogue." OxFirst said its sector-specific analysis suggests that major companies have focused on AI in the medical space, particularly medical diagnosis, medical simulation and data mining.
By now, it's almost old news that artificial intelligence (AI) will have a transformative role in medicine. Algorithms have the potential to work tirelessly, at faster rates and now with potentially greater accuracy than clinicians. In 2016, it was predicted that'machine learning will displace much of the work of radiologists and anatomical pathologists'. In the same year, a University of Toronto professor controversially announced that'we should stop training radiologists now'. But is it really the beginning of the end for some medical specialties?
Want to be a part of an elite team where our innovative technical solutions are delivered to customers that advance the state of the art while addressing long-term problems of importance to national security? At our Leidos' Multi-Spectrum Warfare Research and Analytics Systems (MSWRAS) Division, an organization in the Leidos Innovation Center (LInC), we are looking for you, our next Scientist who specializes in remote sensing data analytics. Join our team of Ph.D. level peers in designing and developing advanced technology-based solutions for contract research and development projects working in our Arlington, VA office. Fun roles you will have in this job: Describe instances of successful, proven, and demonstrable experience contributing to the technical work as part of cross-discipline teams in the development and integration of software-based solutions for competitive, contract-based applied research programs Work with teams composed of members from industry, small businesses, and academic-based researchers and should have experience working on projects focused on multiple technical fields such as machine learning, artificial intelligence, engineering, and software development and integration Describe how the work products to which they contributed had solved customers' problems in such domains as energy, health, and national security or in the commercial sector Work within the MSWRAS Division and across the LInC, performing basic and applied contract research and development projects both leading and working under the guidance of senior scientists and engineers. Processing, interpreting and analyzing large volumes of data collected by remote sensing platforms but may also include other types of phenomenological data such as field measurements, or weather data Independently design and undertake new research as well as partner in a team environment across organizations Contribute to the development of creative and innovative R&D approaches to solving major remote sensing analytics challenges and work with potential sponsors (customers or internal champions) to secure funding for new research efforts based on those topics Contribute to the productivity of teams composed of fellow researchers, data scientists, data engineers, and software engineers to execute complex R&D programs Under the guidance of a senior scientist or engineer, design and develop or integrate secure and scalable applications that are part of broader solutions, that are applicable across multiple domains.
Drug discovery is a hugely expensive and often frustrating process. Medicinal chemists must guess which compounds might make good medicines, using their knowledge of how a molecule's structure affects its properties. They synthesize and test countless variants, and most are failures. "Coming up with new molecules is still an art, because you have such a huge space of possibilities," says Barzilay. "It takes a long time to find good drug candidates." By speeding up this critical step, deep learning could offer far more opportunities for chemists to pursue, making drug discovery much quicker.
For all the advances enabled by artificial intelligence, from speech recognition to self-driving cars, AI systems consume a lot of power and can generate high volumes of climate-changing carbon emissions. A study last year found that training an off-the-shelf AI language-processing system produced 1,400 pounds of emissions--about the amount produced by flying one person roundtrip between New York and San Francisco. The full suite of experiments needed to build and train that AI language system from scratch can generate even more: up to 78,000 pounds, depending on the source of power. But there are ways to make machine learning cleaner and greener, a movement that has been called "Green AI." Some algorithms are less power-hungry than others, for example, and many training sessions can be moved to remote locations that get most of their power from renewable sources.
An important aspect of treating patients with conditions like diabetes and heart disease is helping them stay healthy outside of the hospital--before they to return to the doctor's office with further complications. But reaching the most vulnerable patients at the right time often has more to do with probabilities than clinical assessments. Artificial intelligence (AI) has the potential to help clinicians tackle these types of problems, by analyzing large datasets to identify the patients that would benefit most from preventative measures. However, leveraging AI has often required health care organizations to hire their own data scientists or settle for one-size-fits-all solutions that aren't optimized for their patients. Now the startup ClosedLoop.ai is helping health care organizations tap into the power of AI with a flexible analytics solution that lets hospitals quickly plug their data into machine learning models and get actionable results.
CV is a nascent market but it contains a plethora of both big technology companies and disruptors. Technology players with large sets of visual data are leading the pack in CV, with Chinese and US tech giants dominating each segment of the value chain. Google has been at the forefront of CV applications since 2012. Over the years the company has hired several ML experts. In 2014 it acquired the deep learning start-up DeepMind. Google's biggest asset is its wealth of customer data provided by their search business and YouTube.
Technology, media and telecoms (TMT) regulators will ponder rather than act on AI. Increased use of AI to generate deepfakes in the US presidential campaign may be the catalyst for substantive regulation. Debate regarding access to, and ownership of, data will continue with little regulatory change. For many industries, the focus will remain on operational efficiency. AI-based virtual assistants will gain significant traction.